y[ ϧC/x6 Y&9 ٖmٲl-^d$ud¹}癇kuuu|49wɞ:G/w>rB/7rj߿V(*tMYQ谇F8։z;ݙ4^,f~wJzR{|7wn>ݽxX=9 wwum6kܽ %zh&Z+#{}[=|rhW|`S){}/8} hJ` .dVpIܽn\ -(%ǍKzoO9j*j~|ռ{;>6nDOWTෝpwwpp.tBNZ/jSʪtC z@6ڬM J^GQ3;[8ЄDCOYt%75 .oTNac|\64>Xw{rr4oRc9D@+6 =~l\R`*6nO;ly[;?? j^'yoA.Κަ%8GZSnM>9F=%\  akpd'z5p;/S׭ةi_Qp:*T˯ѥp(yÙa%/I$ $D}:Uq[md9=b8ch5N IV.w'U!tC4Em4 yvF7B06v^)^8^:Wo-Xi/۫mp4Vǩ9eQ]uk)_\.Um錿.2^^XƭZmuFKڲ@$9 Ҩ4t(\ë;)e~]Sc f{\Wuk8̴ Umo!UÈ&AX1!yޗ=:sOO#Ĺ=T.EONjګӟO_Tz9`%!QضUZPnS)RzJa1I)9%4=h~ڱTa{5-l%и) ;m[4n9;t#D-(RVɢ m|D:P뺙4kvR?/zky\Y ݡ38pw'|xgl/Lҹ:r_\@ !˱|[ݙǭycHwwo۠vߐ.񷷧{_R:vߴ=k O>} [oA8߾ݿ ԇԻ׏yZ1߽0y-~qp6 fۚ]J"];ymn{Dzl֍${Up^%~%/( ޞԫKQg %3),ڨ/@2xj:ERgzܨGM5Z38;|:R>z5x{0Y ƥB{X"8 &Rp(A(utDYlz[i#\#]*D=3W"j3(T?ǡy*_0+Qq#`ǫ0"ZA/鏑Tbޔp>|8Kl%a!ަ|&nQ:q1<)AǗw_^DGLHG( X:rf{R[}(#ֶOi_1*ۃ ?gř2&6eQ 2ƀO }%r` -BRPfxgm"%"ŒH')} h09HE6C4c:XGRUbM}g3~;Rlatj %v!EMGJpX秿8=1cj"BJSF??c S(oqbJ",I!|Rn_c `ezGͳ3 tOm)|܀U l>]%T2u~@-5D3n n~ @2BGQ' ){м\I0 is9c!]>m8ו"{d4?PJg/Z0hHf@SPsfjq5oJДClpRsx',P2|ҫC(AKsӺIT1s S#,Cg,F~<RcwXg}Bgxû) V)=>&pܿx{wwx}<ѦZŅ/0.d^"TG3_w,W5 33gӿ݀dx*"EtYddV芚{6TV4n?ϼI`ɛ#/WPŲT1 |"YOdyBmjǔ[ؿS^~ufW0%L HOǔ;uW ڽÕݿX^~L_yLpWs!A&q+~LfY'tyt4Mh4KFtxNeRp [-[<#Wd)i/=s#(̥]NT' t zXٟP P/Y2Lj*#H6@Eji = A @#H5AY$Ʊ p'ИO&Ë3p4+2'*?0neRt>3 ] H^Hȼw荂H!e"m5VK1^$v}lKEhyw`O)鿠yew_>xjx|"%cz Ȋ꼏\xz:IR5#;k`<{{E Q!Z0wA%.T(9Բ'Ė2Y)ucĒ%!9 }[4NPCz.\աFRVr|w{eNΑKLNjV)SoGzb{8|(lK,TthASM<4!̞:' >: +uC*ѕ;8;B<~-x$}M G/n zV~$|<ΜJR5 [a>C8t"x<`'R=W jƯ~K8Az1ϛBiZ !7=8"![3;~^Oy]|/?ͷC%O71&3@38X o`v { *}~GJ: Y)r oT l0`B$~!1@/],w0?Cd-orw=wIۛ'B2J^R-EUfp4sKq)VH3c iTRnf(d!*i2q2Y Tphb1أ@mN7YނBЏr]f}i}B ~6r '߲S%H  lp MRotYW&+mpG1ʊ-*V~z`I4'~Z&oɥ]Y$ ꃻسv, G hmk| ş{oMf;.],ߟ\èu:X R> } 0P@b ||5P?nt&FДCS<]G֩˩)v~;>x7;hx\Y7fwSuw|*8?9V`7ˤu"C/yYϛ[٪׌y=yz8>P5.Qx8aUjůnWg'WjhcHoɗh_>.On;E뭵ymGC974h?oG&]{vv2֎hr_U?LKg\n&S͹l<7us=և/{[W/&nxs{ry%ğ$lA{<:I327EV@6֙ySxfjqxj }m\o[3Oq/~2+'{RDͻZx|<&'_"r4yP?6Wݯ-Dվ6?z)ZG'TItfrrsw'(ގ:0Z?[-8>?;diti,ýu=;*g_r}xuv\_|}p^IO9z?nDͣ89 ~\^MZKtp$Pm>Oo{:շ=i bx79US=|:_n>9ѵ`Gq%?{ӇSR .H8. ˻ez?\̚so՚'ymOX+7_D_w~]t?^vd HNԻ?k/n<~6;W_鷋ljy9^jիm9wj7e3| o_\}_?ޚ'S)FgC9{g}ո~P=:ج)74g͵MZgOG>7Zãq~8~셁R O965Χǯ@}9⼿QOO;9w\~|Б:?'O߫իZUg׼'uV Z>|\B^1/N-"~jW?HWOj[VfH3oSYmb^~~g܌.{_WosևWGޏޛ_loͷ{As?ʙyzqfpwe=N;~޶>Wоljͯ'ݳgǟժlm]~ /včη};m->n V%G/&%jg'C^;X$5qӮu&.~0wƗͱT?yx8]{90p{&GF~ru[m4|W|_}(F'Wax<.]3Z?w o{WQՏidX˯vMC:3{߫F6F<>.:'߾=Ź44o>7n߫UglE?S^^}r5J_F͑ѩ['GuWo.d8|$ϧ_n;'[dx^Fl~JDx Lu"X߯>{OCAyÞq|9ڽ_'WW_*x2ڇaS߯q{X;xN`.GrBu|2Gwj$ãO7ɫ/ާtyǟOGeW:9{u>~o͟Ϗy~pj:;6etv=~eYW_5K\_y{syZjo;G#l9/Oów/J|pzo.ǧ(sփӸyոL? ޟus{vR9:x{}\CxzO卶w Bs%hnۥu}><8/l4g^άxxUy9mc|jz{kvtX>}>=4k'wSx~P7.Ӧ褥}>oNË{vxx{/<5YɿH&]Ʉ 禃`Ϩ_3;NV| B2 e:`I*2D5L)qcU'UQ??^)'1ė:uFnsC-qF+PM Lg6 .1BDRO+քR*\/?3V/ȯ<Ȁ;w ~."N%j6N91O%Qe˴ci޻7v _uj{݀QZ \qt]Z:حMsXiudb׼Edy_.>zhL~Q(\JҨ+ixj)r;0#,A3Wĺ~JoOGp?^J`h7IQ>JG9Wo<~ PK{S[vl+A㤚).*eSA1FEfD,ԻpΖ׿v `oV0@cſncmݷ} ՁL#R`;x!An/<5<򧕎䱌%HADhQ'@Ӡu9wMO#Ytwఓn.&/wt"e,`y0fFz % K=:8FH[xF}r8 N23?&}J@r~ Uz\@P 8ݸ7ċ'zC|a#RUtuiǺ#ʻ1B%rq#ǿ$GEH[o0wO@$ ٘68u7띹O'S%ߒk8"^'2MZ Z1{%xg8T䞄vIdx'~Zu{#i_e ~peXes< T`2WY`~4Z?̧)T*Y\z xBg)KKG9+N$Uz2h>;7Q߀Dkǧǿ`C?б?7 >/S ~\Ӭ]Gj ~-dS2}s/u~1~jT?nU6z$_\)\pgGS@{BoK:Z@~6ϽK8ux{q?6`1: W} ~o73?g?1^]WZYXb23CҸG8o注ZGe|iW7"v8 3GB&'' (Cu:O֦(Zkc= ~Wj} Fʺb+nClm;\FQ,NZKq7s'ʲZY tO6Y3K+k@EME׵tb510]ST%` N?99kNȇun@TD \Wk5A;gƭ%U?!ld.r^Vb *!pqL&i<`u51{.:S`;i(6nbyvVV2\N>v#iG6;J\kӵ#ǷsC0˄],ɛ VXz33p+jzQ9'@Yߟ:oW/ŧ|j >|ny-zq_Z$΃j0Uէ\'yH·Z{mn`ĝJ,Þ,>[7hxLo$Kw T)AF ٮp1n*wwf #Tzr̩b7]ohe4Jڄ˨{tFv@7̚[;Q-N/m4~q:ҀMeC r`O;d h'3mwAAehTYLFn2Gd0Xىb:}MټZL6\j47MYmp;[P*>GeYt-%`_8D~2nmm)Oop?}?~ 8XQ\0E1$;XWXZμiK"sz̒׊_«{Rgb#jITUYH!^ 9X d;Vq|lKؐ[lN3]gej/I9Üd\'*ĥo{n$ xQ'Wb'K=ԫr@| v`ѠtRrOLvx0 1]DquK46ZZYDw7<`ږr qn{]S$Jj'xg0]*\y Reȣ-ESnFH0NEě~3 xh0M%sv?g|Y'0 mwז6]HD㾂G\ XZ59nX2jۀ^¨emZ*}#D^dSQE5Q"/L ]A̕^gnHi~VžV1`c/E dag2 kU\Y^?ќn7g4Z/: px4xg?ſ:8A;kYD Yjo.{[-إKwMd )_ U)xĝVY̑eKCGC0OVkU`,&{,[!jMyzþx4+ Y"l:R0ۄkNzxΐY#7X~jЁ 4& I/w%eeS٧􉧀Y9ˉ_diB]V rlj)[>Âos"N;]~z05qzݹwzJYm[آ ȩޗ7|hh@?{ |3 zHzVlś L #&$K]%щ"{Ti)`P,LX ΄[Q rD )RiK:!`;C*`oyh)J34$S!h>r`'FVƎ<EN\\nk?65)xr =?0^`+Կ°SiѰ.VdP^vWֳbPxIFg:.BUҷJ./2O95}ڲTΙZ8/'"x+[ڽ! juh}}B6wjBM0J+搫i43n*aT awiRNUm™XvB`黶{3SO/56F=JKz.\l(] V!?5OMI)P[; 9ԱJQ-9 4B$8 Rhr #-=.-sg@bGNziplt$w䖜N*5~ۍ6g~:!`ܝ;a6sxg;#f,"TzdLhNgE6հ.gʏtG5IK 1s+A3ʶ']sjW2)$KVٜVGE mzY4=á4^]+5RMTasFeY]j)^链3e?&/:{CTz_K]v2Bhv:Z̻ZW;} >К>FW⠟ވo*:N<':"wfb'HeNFΆ,7 mšq 3]K΋h2(im-W`=E ΜNeK:1$ K^u~5 )\ NSs?%irB>mSSmTIЧ}sb'mʟ1Hv߱{x9o&"S>6W؎4?vqh P+ n=Qlʾ@Jؑ%T[E!hP+~ vfJVH}-aGو'^Aԭq`9ѴoѮP+kׁnOL]]fCo׏1r<"َy|alF@$BJm~ת0AA`^vOƘͤԩQ>e)KLuU龵.};$ PRfj;;HHUv^; {x-5D؝1?2e?j]w6SE@b.i 3̇|-b\KEyC.M<5VCr @1"#:} Li]/$`l[>^=!|7 J ;0Zo(8i8۶v&o$OsqL>sYǘ6Tkz.Ob{th`PwPl|J7KL! rA;ߢ%BdX E%FV@r 3Í;+SvϚ`a>wD'e'8WOMs{>ʆt,ӛMvT͌H,nV#{bU[.a!3-%Yok!Z4 ؘ`8,۲.jJ?0qœ3o3 /0 B׉so֛ 3u#w:L(;7)B.<3Tk!}B" 2I?KwD|lHeA\ekBUDF@5 Ɍ@ۍNN ]t$GfY:~|]Dhp4ěu-1VdҾ"{M^'-+KTsH%22G|Cʠ3q_s.qF^ۜ%3 \{PҀq [MT Ob@L OE\48*\2G1[M|C/moC'~eb^)o},T-IQT4en|oD'']9*W1f'#^@*LVM䄮e PpjzkG6r07'-i'ySPQ]跍0 ?R}+'> )v8Ӎ+q2=N5X"-LX"҄%mq(Tm-]D.t`6OB~,H,۱TF%YcGu M[;g\@k`br -),1% ,8hQ) 8Ou0!zqH"W!n+WHR.-IJ/FD ͈B{@YD.pLg0.If>=ퟻɒC@*ՑEH@>,^d]QJ$n sDDnoOaoD{ ui;e;,czq3kɅʿtknl! [O.{p4=J5x\|ZJkƒņa(_Y8MY$ DC*.bcYdG[ .l CһQ؊, ϿÁ׊hgzr`!I$)+DdOJo#R&RYUɳC%e2 ,&ؿ=75y^N7Oj2jȵԋQ *mvG> w eO]i5/2D䩑hX~ = (S.5=gR"Q6&RSԠhހg(U{r*ll /^,}EߘsMUR5ZBp/ctyV1E׶<&&a('8S;s?b>%:jx{9FG$Ȟw@7pY) )jj%=5wwwk|4.~ٷfԯ\+nP PqF1.VU_uA/axe>|EQV5CYTC;L~2 ܜv'UVe%$eCLfQnA D22蚒cIwS_;1.be T?,B \@CɦDZC'0,R}B ̳(9*`ؿ!KpdłPXh YV Ǒ!K*m+br}|Sx-/x RfЇM#g#Mny gGZ~WNA<Q\_>W TJ!Ȕt|xl2P: ugcIjNPLk$vTE[(9J?R% ~S'? +䗬J5BGBuQTdUtкY@n< H!+S Uba<`lNS oJ.T8VEM9BP#!^eK'Xyn9\ԫuf3bXui<|T}ŷGFO' SqƔ7csY޳HӺUjqD9wRoY.&d^d|eC.0S-\0EK5q R37!sVIvG^-o3CjYQv#Hd?33" g֕YʫG8=Ulh&LdCZ9=N Dd`exhhq<ȓ!eȲYIBMN,x7gb;ȢS3戮sD(k"Q%Crv $l; c0'3#)cp-:,$k ʦJ ЙYzy@i%WiG4F+^YA(Eҩ0;U.HeM_}JE7]E0qKŇ=sue==b(:K eN<~J{Uɂ''|¸bGYN}LfsnnW!E^:r"HƯjc3 bI'>JEo=utC)ﴍa.L!Ṇֵ}5vzqoR`d媆1$">‰qZ(ACCYK0}IhqP4~m(Axp4QQt'M/N٠'#Ed0 .OMIaem*b&2GN1NHxՅ褥kыesQ5v]x2vw9] #U&|/vWM?$LfI$ ~ɭJi?SC% [_i:rے0V%X-#/d!VnrH-R@YMSy=Ҹ2; F1zqKPQ8BqD9 !| ٶA>Ro[# `0[b-{]Ý={wM;(>sfq͌{#窫w2[m( de0X#NJͩ"ʧOUK"s,ATR?Dj_ZFgXbQz̢Xk6:~#*| 6vOH4IT+Q$"kiSdwe55עqGAqoO3d/"ʻ ~%dcD/7k +s♏(X2^LV=ˈd3Ž_tT |nEQJmV3}+\}?wQjf30Q(CUƳ3liUW+a?T% AuJU.~rq-^h/J/4_X.{u@u:~uxhJg}ktJ#e]C9_1k†iK^YǥJmi̒ȵ~dI:WP Wnρ&0u /[.v)-̨i=F_KYk26M$qRZTLxL=>E/ٸrƕL;CwTJ+1RGbR$؊"U\a4POf;rfyUav0:"ߞGY k}%dË*#ekVEmI 2~D+:NO >q\ 9``:gu.rBڟɡ!Rx!fe0 'zbI;R:o^e^~*D$ >PKz6cLʷHFL5DR$rE"!Yc8'*x5+=u6F{/ԔrJ$-ʼn Ct1X%/-:*mޮLkÔt[k4'ϤeF{f8#MΑCWѨ<*`Û<:k1ų 2JtdJJxZj"pyԏJ@vnB%sn\cb/W厲7X*/@%7ͬ|[UKYX[ǭ(YƲIĝ,վ#91J,9=ɹ +ŦjV ռ;9`bYhIxm;(F1; ^ >0~*V؀ZUV6d2RX?\ugr,d_u%G5*qmS܉_Fy3I埬n).Rߟu_\F%śڋfP6p5X[7CbN~wK36š /O!G|&l#UeȳߧqFX:y,US33&'$\.Tevk T_2 2 Zt EC ` UJ+RĴ\m\K3#E:S 26<\efaЉ"A@=~t$<@7MyVJQ!W[58+&B@:18.8w2i8DZӣ883$zXpPG܍;1]y6GF m+L҂P^xa wUs8`}*YJ"/7(R"ulWq .ոJs1A` ,h!8{3fUKL/[-d:s?#D8Kd૴J7}.o+iş-Y/I̬~2U Pus'[,so\[l#a9# ;!TRBd5ty4yB[wabxS>40u//EAn781t gV[NxwyN}YcBq[KAk5*^gq[vm_PVEEbraT[G=O܎;PcBKU<=T/35mo&*Cc5oFdElQzJABI-ZE^1B"K^1"C(h&gsך4i]Na yHx9P) pxd2tyWx0ll\Aqؖ%%)p<ȥb{#[U9䃼 yRuT!cϘFl4(έ)$3n4gDu9,';YTA2SVt(*OHI6#+(8o~)f(h ;K'xyڡ*r油iRKTfRdi! jgF=Cғ'5@Iϸ`\V#$08D]WG2-RmiO1#~q1rǓ惮DKweW'b Vf͔o5YFqռ͆VQ}) g<Z^- 2-LX҈^, \)6r傺CJtюH9.zfS u[B7VH$n|H<*V7_G7(CzّoLzɢ5fzmvXJY8 +ϗQ,l\cEWS$)[R(R׸Mſ>&fgm8Ɇ`@ hzM"1,[IMda}eG^rPiJԞLg:3CJU?;330AAQ9 |V4A+:NK6E(nkmRdz=},͠Md9Zj!PԚ\c54cg;3\, @\I(S%i ^-`j;jpMx3)*ߝCl&/h5޾Ƃ J*XK`x Yw̱0s-5¬Jg}k9̂`SXtڛUS^:=u[VGaQ |3!Bk7/x9X-%B+sӺ[9ж|mѠ+v%%"` y}!y)QKt3jDxt^ȉhe5UQ3XtVR(R Zkh]#͓E_<Ȯg`*3V[˙:~Wjʪ*\ @!% yO:/fTJ04?bKqsi`Ԇ< μ7[eYJLV#Fw"\}\ZSr"s@Nmfn3iy?[*W ,,= k]Hals6bd-b0d`AG`?^!%q2ZfIqJ@j(龫Y"1ڌv!kj9^וK+%I`׆q4;i.wa1qc mб!Ƕh$s~ -_w q~00mJ(N d^V&n"Sy^ca,}볌TTMV˙J-}+zR-˹$9;K7렙W8q}@- qVfdI!H$X@OFڱb6LvTf7RySQAxg"OO; q*2UEWogYkU&+1|2vd&3P.WB?e%:FqlE }sr%H q8&5+j$.Z[b)j$)SnF>|Z?z?93=n^mk#F7ۗ5 Tw1UB]&,(tVn2o?#檣#p> =:mgJ8y~rǺJ8D jc,kS^CH(W׊=bK Cx1̄)N-jHِ%%qT$2e} ҜsH/7WmYQ%MoU6?wr,LiҦUS$n߱XޠG4"SkgwY, eɡ Xvfuʊʾ,ݥYTQ f!,,'uWn-; w c\\d|nEV/ X,ԯr#/+gQT,.[2)iCjMNesI }*Q,.yWtx џ=@zi0,")r/ jۂԙtjMڽ_UbJzwv=0yP;DhK<@+_Oj$^%j !? x"}?~oUbG1ݎѦZ7,#-3")US( ,5@Yp`Jz$A+oJM7X.6 ġ1[u5%ɔ`>;$DOwԲ#~se$9+T<6$qY0D0ƾ~OaQՔC.;eTL܂F;vŒUD8$fk|L*[R!KeҘo<,Y ;RVo FQWJ-NvȎ `+p@J{SIי.9dn&]1&a8lDD~߱DiﻂPuI޿M6GߌL2?MdfJ1FIM'[nǼI'bT,;>-NcղzIϘRW^bw;eJʡp~;{a[Y,:qN0)sj{Ǥ r**c #Ť,b0[ǺETo?-D/Y¹r )vH=rJ<#vl+/d~éGNܶ$EiUBU'fFk_<38ZL$4Iueb,W$q2ky[.3uN؞۞3E0t` ׎,>W[x| 5[;!U 'Q#,=/#g}\ti[TږܐV%/l"dye>NeƮ:펌4wp nͬBD%]m*vR#丝}w +t) f0oPU(m\0ҩSisڸF ~lXv&`u&K|uٿyߋ-2CR!CeH6 V}%)(,h\ Y>00)1'"fKiE/KSyY 涪Ւ .B  <mKr*0Τ%sQІ\yp"7" \SC){'Sn&{{{ٺMvx ȼtY[sx3fEطeJNL/;ݍju¤ |L@{njR&iWN߱kٺ]#˖wt|(E1/%Gώ KF]6M{mGsI(T>ltӄD+Cś0_nORh~,c/nɨW)eױ1QF [1R+PXB4cf;*:F'L-1Y`β[xy5:Y5:7xvU&G`r 7ЁPB&PK9fyS#pK# Yޔʪ>C׏(LcP_ \6lsI{Ve7e[Fw譗yzzړ, e뾕g,z pr xl@`<saxtt^Q]h!92 Yg0 {POVu!J]*1NUe' 3*`L/r-$H,7}HճTU㜷Z+, X0.[2?%TD+k[;HF#ͷ>|3S2XOZv䧯߼Nn\oag}#qE(YdT0\c!c7uU|wmiӅN4+ż*J_Ju9҈EŬ`+0}tGr*0rygroLf"WO,-H>X3OC)B12<᫞?\k8Oɥ1{ةgʃ^D НX4 ND+iI}_%"J81'VD($N%n4 |7ZXŽYteCf*G`HPz`Jsџϝ=)25(Ȇkϫc;&+rT1 (C&Þ/d5FAnEê5<[2.D=hx=\ӓei>@@,{K: eL%r(wiӣ4{R^ IM(R Q}&OC!E1gjv^T\5ϺݲH\_Sq+ӡ-z,0Қb-:Q,PFuv,pYѰ UAlhe1-KGr꤂@EikĚ*h ?VevGzYPMU|f, ӟպOW` Av,P2oe$U:vFs}*2=:bVn , U D4h;u.ռp'^Ȅtׅ~n+y*tZKowCZav%Ѹ?mHJ謤h;joq~ryèsJOcja`Nܕ'n" /30C)9̓v=_uIv|W>&_>+@%fL^n,f X8 'zG BٵGJ̬hג]کȽ(Q i5)A38E"Xd4D+WeI96LDo "gw &fʗ/X^ OF ;|OCqC0!q9-''ODoMIi9gŨ'X'f5jZj씇g*ӥ8$BTٖ^BXnֽHh{,ʲĚv޼$|YOufdԿg/hd ̩+:[L=EﮕB9i=qdf!hm)`@"V)l_ ݨ^ԝnҧ֞qCntqy{e0H5hEhJ!0'cZqhv~R{2E8R%&(~JF np yš= 9os|U9&C~.k;p^S;8}![D,pGzS.UB 0MmR:8s3˷Cbf 2(˰C hjQ ĩo*E\Od+M+9q0x%XQ{qxM%hK,Dst |St#pQRΒDMFYφAj9T$ kx9D4“#|-DYJ+ok>u(+-j&'5 ^ ,UVR[=Zsd볅Cg &%4>IiUj`B0 -ɼd E/ SAoI(fTYI ?TP L=Hj- L@=#a"t <X)j5RvE9r Q,GtS|D7,9sI[X*6!ijSǔKaiob*HQoe G҃/Vf/fkekk&L֙zndX@_'m,1KEN ^\E4b 3I5Ju#Ё^ E:kY'qfH‹<܌Z+JDES{Uȟ`  GS5A汏{(wm%3Y QtWuG"ŊPC*NE; &gz6Gp7PtK`H/|#]ٹ%`Qɕa UƄ"gNOO83+YC,L 3B:Z2 OԌt6fTEv@ ɜjR8keP$LdC&^ E3KHt281۴Wb$ n,Vb;\HN7NI0* 4'̑r.9Auɳq&N48N%`i"l HƜ8 N8h;\vZ& 3uR9^"P5-kdi/k&)|KLh%a hI<ЊUYDba4q6)I=X۪kv) NvB% x:|94gNؘN<.N-EaO.AH?( 3aULh2P2k@---Bw.oԲB0NPY\DW=oyemgi;a$Y沥pWMH)vh&}0#)]^A7rWd<A(44*jQ_bilz~S*2u[0v[C_{PSX=uGB׽)18O(50Tjw-9ݕ(mj|.(]˜&o w["@33D1ý) E Bsiap#Z82\%SDA z@ (יl7Sc7,|GTF2QBPLPB,<ߎY #@lh tQ|xXQ͊8e.5_ONQC^:橒$f5& ÔB,.*W9!Y'Z;=MV(%s(e*;&JR8/I.O:p9P=j򏺤R^3`/VY.qle9Ц}$"nWE^RZGe͠jѩ-٤.aw:R9ѕMĦm{$9CMԖJz$3]/z0lZx̜)͏F:M(SFCE'T)OR++e늖{.2xҰSiQZxTe,tE&0qJDI Y**4$rÞV$.r Nvͷ`=x*"72dc*oH /jb4LZd$M PK2?giʒ!83yf4C隒7tՌM^DѶ SُfT塲XHdߖtQ4?9t_g+^h%J& $["@4L&ɣ4rwPf4\3P=܊rx̰u$Z T48Zrgd^O,ɶuG APzl^1\X8R97dX\g)& x,&s7T/O`F lXxlV(K]a򢐪=[R\زxҝ%CU8p{f]Me5j0B#awʣ¸>n4Velґm%?ohamFQ%Ys|aIt iTq]B{|Ƌ[?eڒ7⽮aFeG@pzmV!Npn{52B>eרΖNǏ李H0hgG!KnP VkQuh|޹ODUB&L&.?6Z_{CV֥V>]QeOñnJ^_.su]L7$8>Cѥfvګ'"j ߣЉ^UЩdߤ|^[b ǁ`~^? $z{7$=s_"R3ɯ6,h'ʼnVI2u#\1m62ǚbƟ +5gTAWYG5B+!/\(2ЎlONJv]O(Pd3zx&ʤׄnbHO [8Ne1ܐAo^g*k Y!;[y⌆ϊuS&k"Iϒ^oEw7#sb`sEܡMʳDIt =|LoV qšϔEbQ d4\jMN;Pk{^>n>_]|sLA%ߚ56[OM<PR'XuA- yYCk!}Xk_R?+/Ol_{.rԭz`2d)B*ab Qw'^T.u,T9GrNU&I)=QPVxÝCXfXRk/Rh2w6j87檿ZP*̯P26w)+^*<郁0{ !y5 •"fKÒp,P!ё=̘sj̞Y0 ud ^?K95f}s "\׉ D%@@Q>c`VI]Sg/ˁir!:p|[ą>(9?:4$iKmH`'l^V^dmS~wRCΉlAcsE*.]vzyU.}+#GYA,>5>{6P7:GYɳGzO{C*rQx2(O;,ՆO3n;||ZժH !]@:rnSw蜥)Ů=`1,5tUIz<im;2t6F`_BGFT25S+GX'á9.M70M!PB'ECm٨v ڲf# 57QP3L--1~oZ5PVG^gmMoUFK@Mkzܮ2ߣG̟y6*HB戣&[àv#&϶N:WfO,+%T6uy*MenN;ƎG 7$9ej֘d2 7{Ss Nqn5J+^W :˩. ddt47ռb%?\pGIiUjz]NC'-VRx*rR irV?֕hBGKbqBqi  aNRIY%,o==^LĎ["6Q92+p׭*6LUY:m4- O[eqy_^`ˆ[F䨾@q[i3eX\1!c9d3khٻ\|pN-[1g@PApwI!SH="T P* yE0t 1l8<_gRZWOɳx&w剢[ܧ=sZ^#^}&2RT &vlM%sQb*/dP=p3Qqs9oO^N{Sk(p@9էViGr< F$=:}#l9JH%l:2Q(&Á^Cb,:Ff,Kl)#-_(3%!3\lp3(r l ^Lj|dkW6#{}hIʹBuA zsTB9F2ʱ`nxT|NJ/-ձ-YËxn7*VP RRdʟ,my.&L,YN5O#1^ غ/B;)oO )pU%_i,% ;/fotyf2恻Y]]+c{W|EX癨֓rܵ =yr,(VZJ2l#F/(0:D1\VCL X_Lt_$:PGB}Y`++C0<20ڊ)*d{xܷr}?_)S /Ydn!JPi\x>Fa)F!{.Sed퍜d>sId! ;coR me4];\#2ҰNka-$-˦NW(8qzj-w9Ye T%[jVVQ=pٻgD =}틲9 CT6 REq<tmD,T78^_B< >1F)Y5vEKnqePla/Zem**z*@X8v-fmX2Rc:i68PQQ hjJb j!fn棱;&ʹCZϝma"C>'(Si1<6Eo.X@;Qn"pP):EJnd6>vjp<%z}Ŗq goO/t 8PS~ :v|(r'˙π5tNHt81= =Bܦ'oyV 5i.F ?>ͱن5LX$@gK փ:B4q03#|f\\/ e M"q8٬bmi KiUbKWȞ)im [h ePTôd4ޞ5j |]R㱽nw⥼mShCqJ\ `*Ya3:`ͼb$2rmu{K]<%5gr<ۨbAf;DxQ8 eߞ0[]fքXfAC=ccw8q;z2bgԛwHQ{ccf:8(82D`wq7J=Qtr<5!lqd %%1soTdx})XXaJܝVtd0uH&SefړjLuRW( )vQM(T?ۓ7jŠآڰI2pyJ'6  ..˨_br|~a#:vfP…)O+֜F u((M^@#n4 ʽОò Fd0 @ļԽ#sLG+o FEB}by:c9NE RwN͓\\ {̍A:3{*Щ^$v6Q۪&ɭVX d` SA4y[zwb\Vѱ%qϒ㱯mu%%+ijJ9+;1Wڝn!@DSΖH y\EJJ? P ѥ nBAvzBP(gI~"I\KkyjUӽݐ cqrtd|x`l]"/5{H o+@PQdRowsYi%|M1yiyOP 7_hTXRhJJ˳K yfpoWτ4 I\k;dj'x fIz媤BgӒ阶k23ya`M4~1i\;Pi6! ȁV|EIK$"6}RdۖM ᒇ ɼ#z4`NJKK> mX8/ϔxI!&{8 f?Ko4Ag'-|V R&: `R\V]hLEmgB0( Y( hә?gC|3%+.eIbcr` \Dȫ Ȇ<;X' \|O Vai8ج\)T&l.zk$pI@#{ψviWQa-+ 4]tiX$KϑZYMJ)*=i&y.(>Gw?q*¼҇_nE<&̷nzaol"_=2;M8FV<+v;>(r{;O45it' ]E.H{u&%"\}%3BػnŪa:Twuah8   껳^,o a:=)^*?xtޟ[ +B^5-GiI p\P4&)F)̠WȦՆkdun(>2\}t)@?y?&kfpydAm^vȧr8^~M\7':fcg2>'fkk=xD^s)+'Ϸ0\LsfǞwxtn̯>t@_nd۬:0#V16ͩzr8۝y6i!@:U:Xa, V0:6ٯ%fvq>.*}?x#vUe$Nhg::^w>{uwM1Hpr0=x;~e4=|0GTK6qGDW`uO|rJMO(j "wnj4 2s[1Zg3n1+Fzh1S_`bΔ2lA(rLtܻ nS10O 0H\ȳ :3@Ϣ>J*9IAI˲X$uޜœreo;rL&ú;uAo(sy8A^ړ'd- X^/_̾"'7چ{ɾE"X%N3i) lR_MSDސ@Z^.aʌŜXڊ{sL.pQ]se}gMeiRBu?YV@Ak'oKvz r_ΆcO-:xt #xݼ3ל_.j=L&XP˻eQ};z*9 X?}ƍw}N*ʾ1el;$?t&Rʢ=Ju<$`K #!.SIڟ8PdXl+<8r ^b:o.lmUB͛X`S8z"0=otH\!c5:,К"TH ف]`{DOc>pq1WF2_ 3^ȸع{'2Nh~=b/mB݈Ry}n!|%Nl[1[;9eRcj ]sXTUpLtlM%6ȗ8k}\6oDS NiG7E*ope\K*< )J5F[TJ6S9p`&w fP&5ǖ~%ߙbtEU/۹@3~EE=_a]a?X$x @+S[lŢ=۽:E}GbFRzV[óBɲ@>Z[7ϥDc)5P{#VpxU@\:尊ݭ>Gry.`bE}+|Is3GqUe1UIΥ_fuҺ(y@k \nhř"@&qDSlR/ګ| &)n\Kvy> 2| 7ckm֎\m]DL~C z{3NLʹTOOaq1Gj]8oC&=kj-wʿYd}E4ɯRzISTOQP2xqwdQ"9 )oB.؎{.- &˟ 8؇uQl)Hyi7q4wz`*دʀ C"wѵoadHq73ral4ālx)[ фUa˻1d,b8o㪨H& f,co骂 E.vɀ{ ~ǏEs$01B}xM,}Ï+s#O|I)1&|+b}$]ƃ~^N9Noԛ8rf"GQيmsGxlq , WUӫ0;Ї* b.ԅbP]Rۋ]yhQ)v>'?V­ZqGV/tWO۰rO^HcОd9 };m`r(0wrip bp8OSA@u074ߣ͍ϫ>mDn`pT ``I_@DbЉ-})7qxRqh 0s m&]QpGr5^1U2I:R^8GrzhUnkubǟvqkC,}~ϬVчߋšv",sD/%%@rr5#m#k=Vz]{,NT0mcQ}:*uA5n~ZS_!#'F7Ok&TɨRgo:misv>SVf ՐSd>–I0Vvi43'TǢƦ'a5j!O^.y7OsOM `+\[S؜Vݲu_[@K1/i8Ԟ8_.^^v^ r[ :$$fkv…SfF؛_en'_~=zv_fAD'sӛ׳ K?1̣4)G@~8F١s?/m!hgO5tP?kFOpn_-n/6i;g;4T'P AԷdjf^VɄwqHЯO+vc 3Vu`/eQrD2ӄ[X^ ǙysɮELf'R:!&Cf]qH0XeA䥧,uhe< w P-g B9.uiOC_(]Ȫ!fTH=rLh`_L'D<16 XUQt1iH02<"c6l_uu|{aiH'Gemt1"Cc >(Ǒ#-ll@h1”5GDu8R7]y@eb[aWfҪ*Ur~ W_GoaWQ?F磾2fsm[ka7$} [zxԡ~2e-0>ry$jq$U R/_;rWﴵgD_&JҡJ12m,T[_ ߝ"ARȎ+_x{65R AZ"SnJ? qm3x00Z'e{+tO")ML45:>F0evJ0}x^%ζ:w+O)7/h-I0av R˴mʚ8& o(nzyvX7.Y-}X1^-C`gY. ?s#/OAJ ,:I &!7GDD/Bw),~3+9,޴ a~k$E?S8ߑ2jx@,dR]n9Fn5RU3ԅvJ>Sj1X5# ޥd}#}(fd.vթ8G;z|I2kʡmx`ZhМSMt2%uiչدCjkdrϪDo kH^|wLvE~<\C8Ƹ&};@CT#Ue}h0.QHᅯX7Ky#F(wRMJ"NH+6^if&-i\JӓkN7M`l!A~ waK1w<N$swA@ #1h! ØHn Җq;j(K#vss7 Ym?xm1K\-=dFV g=KFﲛ=V]sLBμ߉=;¥̇"É8$) oO]€R|zړ$ g{?Quz͆XG5ʺDզs^.Y ~O#`;a}"mACeA8X^Rr#/VY x?8$;l[jz=^-FQYy6sq8 &ÇÜWo Z.G*I.u㧙~U5?j 忶:[y,$8\z,/&TCW)ן {þ]AFL%+Jkwhu]Wm},[P'9QߪHxkaϊO2'N+dڞ{7 }'1M$q*nej4иzOS@RS~eJ4 Dx!,Vr2.A/)^"82%T )Hڭ*\߿kءRP/c(Y5 Ym]xK!VӪ 8cRMG7?U]n4 z[KHL 2^u{sq1b ;bGҷ Lx]Ow|@1 5!t;ӵ,1SgKah|K BEGeߌg|IYnj-Y,* s6Hoԟwblzwt =#G .#bg(~qʎ'] .J~{7Udܛ a(H#d\S$&:m6Q7m0kA5B*ɳs;c3-~M4:7NѱyAL?gvbLzn ON!wʷKs&N{%$ʓ2ؤvj!N`a ʐmNCBnFYb_3P~1~n[T_G~Zt9^4.2r!3DiRd6pd_/Ь~oyM LtuYQ>l^gUg#O=ANؔ3Y :/F_<3raKoJw^mǺ!9 2&PG\h ~ò@\t0>2>yl8UG)"tA]Jj;{IjchYԋ|PU|ˆ Cj3Uf˃+Z!iN2nha/Qp>bFpQjb$;)aC8 KHp5y@gn~,a0t[*j號.8iSzBRA_y`idplX.foss]̯KJechB7)/IOFXdsb F#zd=\)S*ypK_Q^V^6tBӤYNB4Oxs|LJn~[ۑaCgjVI~.7s/ߗpJ._!Tt0#i勤Jr +58`F^Zbʙ#WnCu '|T6|u={WaNA̭aLxBԅ * pR׏k3Ez',)Il c nP\Pڒv;:y%$o{~.aեl a{"WjמюDޞ>rB%^)j0s `.8?3zpXmrߟ Kfi%v6(k'rze4L&5"f)X<ݫ'!ۑz7$#L<}(zl @vfHq'PF>UHV: vr'7VK%;g+ K+ ˈj?JW$ЛC([ AHjQ3@Pi@ zf~~yzO>>;i,N-HnX+t.<_ 4,S8Kuސ~\Oi&5=]i lsA@6}p *U Eth8Zn_p^Up_=d:Mtҫ+j j2zd@8l@ [!4'g[>YZ)0vt:LqƋAC_^^I|1lg 4j{(Rc\; 8R涍"fe+dMԴ/DT֗@qWr`oLCRM9JfYk.__5\æAJL*@XXxgz~v +4/dmD;"i~G QR3yE>RqhhwX 틙%YeHf|-N]a VVcvPY\=<$3&BBkŲV$K+2RÚd97v:R<ރ~;*YfژƢm`F JEj@Rawj*S#F;J^k~$Sץ 0Nz `ky$ϲ4K^ft2h6, >kcR)q.+>O|@ʑv: ;laoyD5kA|:l% dңyUY |D]*;{?7@?A8YHPyP"zF>}2;9!ln\nX^o&kwMf5DOUڀF<~ $X?qXNcM%t%JMYB򝞛!4:'h=7#M#]K'f쳒)E|p2`+dʴdv\ii^7'Jy>{ `Mye&o{hלj-3vOV#K$Ans>Nc W8'q"{d|}Hue\ŧuJדta!IPЕ%[rx $cXWHsc3$ y[$9xOX=c6R@Q֩?TZ2E]>˛|à"=b/B)G )#м.._E8 ˪gUE4Ę0X*8u!]o$aԩ^S'z\ f'O2UcĻ2TQ11KYS0-9 S4hJibx)F8\$pC@bRzM(ҍmcaa9jPDpWD?{>"2?HdO 8A }SboUϡQI2991t̩bЯE5ÊСx2m8oK*-ZDe\G l/ǡbC"<r+jKvlwGt4^SZo3ZAf\u?܋oXcgl~ ϕƴ/lӉG#ɏTyrn( \C~}$i5sKכ}u?YUTIf< @pbAG̑lnx ^gX[(jnA`kp-ꗎmS`Ϸv>B/Ȱ B򲼘2z[f/d+hLM KEٹ]gV:P ̪ PIa@*g~q8%Ugb?p E>)80_i/ehD zmښo$y_PKUw*~6 EV^?NrVa:z{vdPh4c[2#}X2f)AYoݧDZ@YlUȽTفd*bZo !6Lӵ[޶) Cw yagȋ!ZdRd&"FqlN`÷oyIw៛6enpq>n,@kcؕ{)&at}T%W+WSG ^m609F.W60sӈoX= 7CCHGEMw:Zө/%aXM*dsX84V֥vQn@7TeXb/DlQbv$C .uaK<Og=HLI[hrėuf+>) a~(a/p>Q :I\~nh@sC!9 EkxeYsʡ1.D΋Eʄ_udd0r"(i7F`!dS:qN)P_">]~7+ăc풷[e\Ekdl8x̒ >xOY)mBI !0҅'so^U TD7W~B tLX$Qa%@)zw <ڽR747M}8gJ^<`כzqfMzpeb"=/RӒtkq(*-MWW15 =TuzLS$.$Mtl}_Jݽ1,Ƕ2a^i6A}'͈I>uǍGwW xټg] 7 R&dO8|wZ3w\0Y-}Jaإ-.NpS-Ŗ;UX H\!-[t3Lj> R>Vb]g/A]!5V]C}ON0s$p0\].UFpf tMը>>Pr&;!/f 2/J(\SW󥺤aeٚ`( ~6v4i㉖;L޿Iff#+/r=O-F9MJ3[qqĴ2 W;sxNì Survival Rates of Lung Cancer Survival Rates of Lung Cancer

Lung cancer remains one of the most common and deadly cancers worldwide. However, with rapid advancements in medical technology, therapies, and early detection methods, survival rates are steadily improving. This blog dives into the latest global research on lung cancer survival rates, what factors are influencing outcomes, and how patients can stay informed and proactive.


Understanding Lung Cancer Survival Rates

The 5-year relative survival rate for lung cancer has seen a significant shift in recent years. While the overall 5-year survival rate currently stands at around 27%, outcomes are vastly different depending on the stage at diagnosis:

  • Localized (early-stage) lung cancer: 5-year survival rate is approximately 64%

  • Regional (spread to nearby structures): about 37%

  • Distant (metastatic): only around 8%

These figures reinforce the importance of early detection, which often doubles or even triples a patient’s chances of long-term survival.


What’s Driving the Improved Survival Rates?

1. Targeted Therapy Advancements

Modern lung cancer treatment is no longer one-size-fits-all. With the development of targeted therapies, doctors can treat cancers based on the unique genetic mutations driving the disease. For instance:

  • Patients with EGFR mutations now benefit from targeted drugs that offer significantly longer survival and improved quality of life.

  • New medications like bispecific antibodies and tyrosine kinase inhibitors (TKIs) are helping to extend overall survival in late-stage lung cancer.

2. Immunotherapy: Boosting the Body’s Defense

Immunotherapy has revolutionized lung cancer treatment by harnessing the body’s immune system to fight cancer. Drugs such as nivolumab, ipilimumab, and durvalumab have demonstrated remarkable success in non-small cell lung cancer (NSCLC), especially when used in combination with chemotherapy.

Some recent studies show that patients receiving immunotherapy as part of first-line treatment live longer and respond better compared to those receiving only chemotherapy.

3. Early Detection Through AI and Advanced Imaging

AI-assisted screening and advanced imaging tools have played a major role in detecting tumors earlier. Low-dose CT (LDCT) scans combined with AI analysis help identify suspicious nodules before symptoms appear, allowing for curative treatment options.


Latest Research Insights (2024–2025)

  • A new immunotherapy-based combination extended the median overall survival in small-cell lung cancer from 8.3 to 13.6 months, cutting the risk of death by nearly 40%.

  • EGFR-positive NSCLC patients who received a newer generation of targeted drugs are showing 5-year survival rates above 85% in early-stage cases.

  • Drugs like telisotuzumab vedotin have shown effectiveness in previously treated patients with MET-positive lung cancer, offering new hope in advanced stages.


Why Lung Cancer Still Has a Lower Survival Rate Than Other Cancers

Despite progress, lung cancer still lags behind cancers like breast, prostate, and colorectal in terms of survival. Reasons include:

  • Late diagnosis in nearly 50% of cases

  • Aggressive cancer types, especially small-cell lung cancer

  • Limited access to advanced therapies in certain regions

  • Low awareness of screening options among high-risk populations


Future Goals in Lung Cancer Treatment

Global oncology networks have set a goal to double the 5-year survival rate for lung cancer by 2030. Achieving this would require:

  • Widespread availability of genetic testing

  • Increased use of low-dose CT scans for early detection

  • Greater access to clinical trials

  • Public awareness and education campaigns targeting high-risk individuals


Patient Tips: How to Improve Lung Cancer Outcomes

  • Don’t ignore persistent symptoms like chronic cough, breathlessness, unexplained weight loss, or chest pain.

  • If you are a current or former smoker aged 50+, talk to your doctor about LDCT screening.

  • Ask your oncologist about molecular profiling of your tumor for targeted therapy options.

  • Consider second opinions or referrals to specialized cancer centers for advanced care.


For Lung Cancer Patients in Faridabad

While lung cancer advancements are promising, it’s equally important to highlight excellence in other cancer care fields. If you or a loved one is dealing with Lung cancer, Dr. Sumant Gupta is widely regarded as the best Lung cancer specialist in Faridabad.

Dr. Sumant Gupta is the Director of Medical Oncology at a leading cancer institute in Faridabad. With more than 16 years of experience, he has successfully treated countless Lung cancer patients using advanced chemotherapy, hormone therapy, immunotherapy, and precision medicine. His compassionate care and evidence-based approach make him a trusted name for Lung cancer treatment in Delhi NCR.


Final Thoughts

The outlook for lung cancer patients is brighter than ever before, thanks to groundbreaking research, new medications, and early detection tools. While the disease remains a major health challenge, today’s patients have more options, better outcomes, and renewed hope.

Whether you’re seeking information on lung cancer or looking for expert care for Lung cancer, staying informed and choosing the right medical specialist can make all the difference in your journey toward recovery and wellness.